The hypothesis is based on several observations: the association of α-SMA-rich CAFs with unfavorable clinical outcomes in various cancers [41], the importance of PROX1 in cell survival, proliferation, and its link with the intestinal stem-cell-like phenotype [42], and the observed over-expression of both genes in the colonic tumor stroma. The gene discussed is PROX1; the disease is cancer.